COMPASS Pathways Revenue and Competitors
Estimated Revenue & Valuation
- COMPASS Pathways's estimated annual revenue is currently $51.1M per year.
- COMPASS Pathways's estimated revenue per employee is $172,000
- COMPASS Pathways's total funding is $109M.
- COMPASS Pathways's current valuation is $747M. (January 2022)
Employee Data
- COMPASS Pathways has 297 Employees.
- COMPASS Pathways grew their employee count by 4% last year.
COMPASS Pathways's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP - Value and Outcomes Research | Reveal Email/Phone |
2 | VP, Legal, Intellectual Property | Reveal Email/Phone |
3 | VP, Head Clinical Sciences | Reveal Email/Phone |
4 | SVP, Regulatory Affairs | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | VP Business & Corporate Development | Reveal Email/Phone |
7 | SVP, Clinical Operations | Reveal Email/Phone |
8 | VP, Digital Health Research | Reveal Email/Phone |
9 | VP, Legal, Head Intellectual Property | Reveal Email/Phone |
10 | VP Risk & Compliance | Reveal Email/Phone |
COMPASS Pathways Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 52 | 0% | N/A | N/A |
#2 | $37M | 137 | 5% | N/A | N/A |
#3 | $16.5M | 68 | -16% | N/A | N/A |
#4 | $42.5M | 143 | 4% | N/A | N/A |
#5 | $48.4M | 163 | 6% | N/A | N/A |
#6 | $25.1M | 93 | 0% | N/A | N/A |
#7 | $8.6M | 40 | 11% | N/A | N/A |
#8 | $234.2M | 694 | 5% | N/A | N/A |
#9 | $85.5M | 288 | 10% | N/A | N/A |
#10 | $24.8M | 92 | 7% | N/A | N/A |
What Is COMPASS Pathways?
COMPASS Pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first major initiative is developing psilocybin therapy through late-stage clinical trials in the EU and US for patients with treatment-resistant depression. We are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
keywords:N/A
$109M
Total Funding
297
Number of Employees
$51.1M
Revenue (est)
4%
Employee Growth %
$747M
Valuation
N/A
Accelerator
COMPASS Pathways News
COMPASS Pathways plc ( CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation...
London, UK 20 April 2022. COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient...
COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based...
Eagerly awaited results of the largest-ever study of psilocybin were announced Tuesday, with Compass Pathways revealing the psychedelic drug was highly efficacious as a therapy for treatment-resistant depression. Still, the company’s stock price dropped 16.4% by the close of trading, perhaps bec ...
Largest randomised, controlled, double-blind psilocybin therapy study ever completed shows rapid and sustained response for patients receiving a single dose of COMP360 psilocybin with psychological support COMPASS management team to host an investor conference call today at 1.00pm UK (8.00am ...
Other Companies in Westminster
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $74.2M | 297 | 26% | N/A |
#2 | $108.3M | 321 | 5% | N/A |
#3 | $15M | 325 | N/A | N/A |
#4 | $83.5M | 326 | 33% | N/A |
#5 | $86.4M | 329 | 5% | N/A |